Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
16.72
+0.18 (1.06%)
At close: Jul 21, 2025, 4:00 PM
16.72
0.00 (0.00%)
After-hours: Jul 21, 2025, 4:10 PM EDT
Castle Biosciences Employees
Castle Biosciences had 761 employees as of December 31, 2024. The number of employees increased by 151 or 24.75% compared to the previous year.
Employees
761
Change (1Y)
151
Growth (1Y)
24.75%
Revenue / Employee
$456,088
Profits / Employee
-$6,661
Market Cap
482.60M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CSTL News
- 4 days ago - Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company's Strong Culture - GlobeNewsWire
- 7 days ago - Castle Biosciences to Release Second Quarter 2025 Financial Results and Host Conference Call on Monday, Aug. 4, 2025 - GlobeNewsWire
- 4 weeks ago - Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases - GlobeNewsWire
- 5 weeks ago - Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - GlobeNewsWire
- 6 weeks ago - Castle Biosciences' Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards® - GlobeNewsWire
- 7 weeks ago - New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes - GlobeNewsWire
- 2 months ago - Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire